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Radix angelicae pubescentis (RAP) has been used in Chinese traditional medicine to treat
painful diseases such as rheumatism and headache. A previous study has reported that
columbianadin (CBN), a major coumarin in RAP inhibits acute and inflammatory pain
behaviors. However, the effects of CBN on neuropathic pain behaviors, and the potential
underlying mechanism have not been reported. In the present study, the effects of CBN,
compared to another major coumarin of RAP osthole (OST), on oxaliplatin-induced
neuropathic pain behaviors and on the voltage-gated calcium currents in small dorsal root
ganglion (DRG) neuronswere studied inmice. It was found that CBN andOST inhibited both
mechanical and cold hypersensitivity induced by oxaliplatin. Moreover, CBN and OSTmight
preferentially inhibit T-andL-typecalciumcurrents (Ica). The inhibitoryeffectsofCBNandOST
on theoxaliplatin-inducedmechanical allodyniawerepreventedbygabapentin. These results
suggest that CBN, as well as OST might inhibit neuropathic pain behaviors through an
inhibition of T- and L-type calcium currents in nociceptive DRG neurons.
Keywords: columbianadin, Radix angelicae pubescentis, traditional Chinese medicine, neuropathic pain, calcium
currents, oxaliplatinINTRODUCTION
Radix angelicae pubescentis (RAP) is the dried roots of Angelica pubescensMaxim. Freziera biserrata
Shan et Yuan (family Umbelliferae) and was initially described in Shennong Ben Cao Jing as a
traditional Chinese medicine. RAP has been widely used for the treatments of rheumatism and
headache for centuries in China (Chinese Pharmacopoeia Commission, 2015) (Yang et al., 2017).
Previous studies found that the extracts of RAP reduce behaviors of acute pain, formalin-induced
inflammatory pain, and neuropathic pain in a spared nerve injury model and that coumarins in the
extract are the active anti-nociceptive components (Chen et al., 1995; Li et al., 2013; Park et al., 2013;in.org January 2020 | Volume 10 | Article 15221
Su et al. Columbianadin Inhibits Pain and IcaLi et al., 2017). Moreover, a major coumarin in RAP osthole (OST)
inhibits pain behaviors in multiple pain models such as
inflammatory pain, diabetic pain, and low back pain models
(Chen et al., 1995; Wu et al., 2017; Singh et al., 2018; Yuan et al.,
2018). These results suggested that OST is an anti-nociceptive
component in RAP. On the other hand, columbianadin (CBN) is
another major coumarin in RAP and there is one study so far
reported that CBN inhibits acute and inflammatory pain behaviors
(Chen et al., 1995; Chinese Pharmacopoeia Commission, 2015).
However, the effects of CBN on nociceptive behaviors in any
neuropathic pain models have not been studied. Moreover,
neither the potential mechanism underlying the anti-nociceptive
effects of CBN nor if CBN modulates ion channels has
been reported.
A variety of ion channels in the nociceptive dorsal root
ganglion (DRG) neurons contribute to the transduction,
conduction, and transmission of pain signals from periphery to
spinal cord. For examples, transient receptor potential (TRP)
channels can transduce nociceptive stimuli to electrical signals at
free nerve endings that innervate peripheral tissue (Caterina
et al., 1997; Patapoutian et al., 2009). Voltage-gated sodium
channels are important for the generation and conduction of
action potentials from peripheral tissue to spinal cord dorsal
horn (Hodgkin and Huxley, 1952; Catterall, 2017). Voltage-gated
calcium channels contribute to the release of neurotransmitters
and neuromodulators at both central and peripheral termini of
DRG neurons (Dolphin, 2016; Gong et al., 2018). Therefore,
pharmacological modulators that target ion channels on
peripheral sensory neurons, are being pursued as potential
candidates for the development of analgesics (Theile and
Cummins, 2011; Waxman and Zamponi, 2014). Coumarins
have been reported to modulate ion channels. For example,
OST exhibits antipruritic effects via modulating TRPV1 and
TRPV3 activity (Yang et al., 2016; Sun et al., 2018). Moreover,
OST modulates N- and P/Q-type Ca2+ channel in the
synaptosomes from rat hippocampus (Wang et al., 2008),
inhibits L-type calcium current in NG108-15 cell, and inhibits
vascular Cav1.2 current in smooth muscle cells (Wu et al., 2002;
Fusi et al., 2012). On the other hand, another coumarin
component of RAP imperatorin inhibits voltage-gated Na+
channels in NG108-15 cells (Wu et al., 2013). In contrast to
OST and imperatorin, the effects of CBN on any ion channels
have not been studied. Moreover, the effects of any coumarins on
voltage-gated calcium and sodium currents have not been
studied in DRG neurons.
In the current study, we examined the effects of CBN,
compared to OST, on mechanical allodynia and thermal
hyperalgesia in a neuropathic pain model associated with a
chemotherapy drug oxaliplatin. We also studied the effects of
CBN and OST on the voltage-gated calcium and sodium currents
in DRG neurons.Abbreviations: CBN, columbianadin; DRG, dorsal root ganglion; OST, osthole;
PWT, paw withdrawal threshold; RAP, Radix angelicae pubescentis; TTX-R,
tetrodotoxin-resistant; TTX-S, tetrodotoxin-sensitive; TRP, transient
receptor potential.
Frontiers in Pharmacology | www.frontiersin.org 2MATERIALS AND METHODS
Animals
Male C57BL/6 mice at the age of 8 weeks (Jackson Laboratory,
Bar Harbor, ME, USA) were used for cell culture and behavior
experiments. Mice were housed five or less per cage at a
temperature-controlled room (22 ± 0.5°C, 12 h/12 h light/dark
cycle) and were with free access to water and pellet diet. All
experimental protocols were approved by the Institutional
Animal Care and Use Committees of the Indiana University
School of Medicine, Indianapolis, Indiana, USA. All procedures
were conducted in accordance with the Guide for Care and Use
of Laboratory Animals published by the National Institutes of
Health and the ethical guidelines established by the International
Association for the Study of Pain.
Von Frey Test
To assess mechanical sensitivity the von Frey assay of “simplified
up-down” method was used (Bonin et al., 2014). Mice were
placed in Plexiglas cubicle containers on a metal mesh wire
platform to allow access to the plantar hind paw. To acclimatize
mice to the test procedure, they were placed in the containers for
45 min prior to each test session. A set of eight calibrated von
Frey filaments ranging from 0.008 to 6 g (North Coast Medical,
Morgan Hill, CA, USA) were applied alternately to the plantar
surface of each hind paw until they bent (Li and Sheets, 2018).
The duration of each stimulus was approximately 1 s and
nociceptive behaviors were considered to be retraction/lifting,
rapid shaking, and/or licking of the hind paw.
Acetone Test
The acetone test was performed according to themethod described
by previous publications (Kawashiri et al., 2012; Li et al., 2016; Xie
et al., 2016). Mice were placed to the same setting described above
for the von Frey test and allowed to habituate for 45 min prior to
testing. Fifty microliter of acetone was applied to the center of the
ventral sideof thehindpawandresponseswereobserved. In thefirst
20 s following acetone application, if the mouse did not withdraw,
flick or stamp of the paw then 0 points were recorded for the trial.
However, ifwithin this 20 s period the animal responded to acetone,
then the animal's response was assessed for an additional 20 s.
Responses to acetone were graded according to the following 4-
point scale: 0, no response; 1, quickwithdrawal,flick or stampof the
paw; 2, prolonged withdrawal or repeated flicking of the paw; 3,
repeated flicking of the paw with licking directed at the paw.
Acetone test was applied alternately three times to each paw and
the responses scored categorically.
Cell Culture
DRG neurons were dissociated from lumbar L3–L5 ganglia of
mice and prepared as previously described (Tan et al., 2006; Qu
et al., 2014; Tan et al., 2014). Briefly, mice were sacrificed by
exposure to CO2 and decapitated. DRG were rapidly removed
and placed in bicarbonate free DMEM medium containing
digesting enzymes. The DRGs were digested with Liberase TM
(0.35 U/ml; Sigma-Aldrich, St Louis, MO, USA) for 20 min
before another 15 min with Liberase TL (0.25 U/ml; Sigma-January 2020 | Volume 10 | Article 1522
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Biochemical) at 37°C. After enzymatic digestion, DRGs were
triturated using a fire-polished Pasteur pipette. The dispersed
cells were resuspended in F12 (Thermo Fisher Scientific,
Waltham, MA, USA) medium supplemented with 10% FBS
(Thermo Fisher Scientific, Waltham, MA, USA) and 1%
penicillin/streptomycin (Mediatech, Inc., Manassas, VA, USA)
and plated on polyornithine-laminin-coated coverslips
(Discovery Labware, Inc., Bedford, MA, USA). The cells were
maintained at 37°C in a humidified 95% air and 5%
CO2 incubator.
Electrophysiological Recordings
Patch clamp recordings of small-sized DRG neurons were
obtained 14–28 h after dissociation. Cells with a round shape,
clean membrane, and without or with minimal processes were
chosen. All the neurons were with a diameter less than 25 µm
except those used for recording of T-type calcium currents.
These neurons were ranging from 20 to 28 µm (Supplemental
Table 2). Whole-cell voltage clamping was performed as
described previously at room temperature (20–22°C) (Tan
et al., 2014). Recording electrodes were pulled from
borosilicate glass capillaries (Harvard Apparatus, Holliston,
MA, USA) using a Sutter P-97 puller (Sutter Instrument,
Novato, CA, USA) and the tips were fire-polished to obtain a
pipette resistance of 2–5 MW when filled with internal solution.
A low noise, high-performance Axopatch 200B patch-clamp
amplifier (Molecular Devices Corporation, Sunnyvale, CA,
USA) driven by a personal computer in conjunction with an
A/D and D/A board (DigiData 1320 A series interface, Molecular
Devices Corporation) was used to generate and apply voltage
pulses to the recorded cells and to record the corresponding
membrane currents. To assess the properties of calcium
channels, a barium-containing external solution was used to
avoid calcium influx-induced rundown of calcium currents. The
barium-mediated currents were referred to “calcium currents”
throughout the current study. The external solution contained
the fol lowing components ( in mM): 5 BaCl2 , 140
tetraethylammonium (TEA)-Cl, 2 MgCl2, 10 glucose and 10
[4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid] HEPES,
pH adjusted to 7.4. The internal solution contained the
following components (in mM): 110 Cs gluconate, 30 CsCl, 1
MgCl2, and 2 Mg-ATP, 0.1 Na-GTP, 10 HEPES, pH adjusted to
7.2. For sodium current recording, the external solution
contained the following components (in mM): 130 NaCl, 30
tetraethylammonium (TEA)-Cl, 3 KCl, 1 MgCl2, 1 CaCl2, 0.05
CdCl2, 10 HEPES, 10 glucose, pH adjusted to 7.4. The internal
solution contained the following components (in mM): 140 CsF,
10 NaCl, 1.1 ethylene glycol-bis(b-aminoethyl ether)-N,N,N′,N
′-tetraacetic acid, 10 HEPES, pH adjusted to 7.2. The osmolarity
of the external solutions and internal solutions were 310–315,
and 300–305 mOsm/kg, respectively. All chemicals were
obtained from Sigma-Aldrich unless otherwise noted. Calcium
currents were evoked by command voltage steps from the
holding potential of −100 mV to depolarizing pulses from −80
to +50 mV in 5 mV increments. The duration of pulses is 200 ms
and the interpulse time is 3 s. The series resistances of currentFrontiers in Pharmacology | www.frontiersin.org 3recording were compensated at 75–80%. Amplitude of calcium
currents was measured at the steady-state (averaged value of
currents recorded during the last 10 ms of the pulse) for all the
conditions except when a mixture of calcium channel blockers
(nimodipine, w-Conotoxin MVIIA, and w-Agatoxin IVA) was
applied together to reveal the transient calcium currents. In the
latter condition, the peak amplitude of calcium currents was
measured. In the current study, we used a kinetics subtraction
method to separate the fast (TTX-S) and slow (TTX-R)
components of sodium currents (Cummins and Waxman,
1997). Using this protocol, sodium currents were elicited by 20
ms test pulses to −10 mV after 500 ms prepulses to potentials
over the range of −130 to −10. The TTX-R component was
obtained at the prepulse of around −50 mV. The TTX-S
component was obtained by a subtraction of the TTX-R
component from the total current obtained at the prepulse of
−110 mV. Although this protocol avoids perfusion of TTX on
top of the pre-treatment of coumarins, we recognize the
limitation of this protocol that can not separate TTX-S and
TTX-R components of sodium currents with 100% accuracy in
all the neurons.
Drugs and Their Administration
Oxaliplatin, nimodipine, w-Conotoxin MVIIA, niflumic acid, and
gabapentin were purchased from Sigma-Aldrich (St. Louis, MO,
USA).w-Agatoxin IVAwere fromTocris, Bio-TechneCorporation
(Minneapolis, MN, USA). CBN (purity: 99.85%, Cat. No. HY-
N0362) and OST (purity: 99.90%, Cat. No. HY-N0054) were from
MedChemExpress (Monmouth Junction, NJ, USA) and the
chemical structure of CBN and OST is shown in Figure 1. For
electrophysiology, the drugs were made in external solution at
different dose includingCBN(100µM),OST (100µM), nimodipine
(2 µM), w-Conotoxin MVIIA (1 µM), and w-Agatoxin IVA
(0.2 µM). To avoid the potential rundown of currents and and/or
potential artifact introduced by the decreased quality of voltage
clamp over time, all these drugs were pre-treated in the bath
solution [contains a final concentration of 0.1% dimethyl
sulfoxide (DMSO)] in the recording chamber for 10–60 min
before the recording of calcium currents. A 0.1% DMSO bath
solution was used as control for these experiments. Recordings of
calcium currents are all from independent cells and each cell is only
used for a single treatment. For behavior test, stock solutions of
oxaliplatin in distilled water (5 mg/ml), were further diluted in 5%
glucose to give thefinal concentrationof 1.25mg/ml.CBNandOST
and were dissolved in DMSO and further diluted in saline (to give
2% DMSO) for different final concentrations. A single
intraperitoneal (i.p.) injection of oxaliplatin (5 mg/kg) was
conducted and the effects of OST and CBN (1–10 mg/kg, i.p.)
were examined 3 days after oxaliplatin injection. Gabapentin was
administrated (30 mg/kg, p.o., single administration) 3 days after
oxaliplatin treatment.
Statistics
Statistical analysis was performed using GraphPad Prism6
(GraphPad Software, La Jolla, CA, USA). Two-tailed
independent Student's t-test, one-way ANOVA with Tukey's
multiple comparisons test, or a two-way repeated ANOVAJanuary 2020 | Volume 10 | Article 1522
Su et al. Columbianadin Inhibits Pain and Icafollowed by post hoc Bonferroni analysis were used. Values of p <
0.05 were considered statistically significant. All data are
presented as mean ± SEM.RESULTS
Effects of Columbianadin on Oxaliplatin-
Induced Mechanical Allodynia and Cold
Hyperalgesia
In the current study, we used an oxaliplatin-induced neuropathic
pain model of mouse. We tested the effects of CBN on the
mechanical and thermal sensitivity in oxaliplatin-treated mice.
We also compared the effects of CBN to OST, the other major
coumarin from RAP that has been studied more. As shown in
Figure 1, oxaliplatin decreased paw withdraw threshold (PWT)Frontiers in Pharmacology | www.frontiersin.org 4to von Frey stimuli and increased score of withdraw response to
acetone tested at 3 days post administration. Both CBN and OST
significantly reversed oxaliplatin-induced decrease in PWT at 30
and 90 min after administration. The reversing effects occurred
at 30 min, reached peak at 90 min, and disappeared at 150 min.
At 90 min, both compounds reversed PWT near completely
(Figures 1 and 2). For the acetone-induced cold responses, a
similar time course of reversing effects was observed after
treatment of CBN and OST. Significant effects were found at
30 and 90 min after CBN and at 90 min after OST treatment,
respectively. The reversing effect of CBN appeared stronger than
that of OST at 90 min after treatment (Figure 2).
We next compared the effects of CBN and OST at different
dosages (Figure 3). At 3 mg/kg, CBN produced significant effects
on both PWT and cold withdrawal score. However, the same
dosage of OST only resulted a significant effect on cold response.FIGURE 1 | Effects of columbianadin (CBN) and osthole (OST) on oxaliplatin-induced mechanical allodynia and cold hyperalgesia. (A) Structure of columbianadin
(CBN). (B) Structure of osthole (OST). (C) Mechanical allodynia, represented by the decrease in paw withdrawal threshold (PWT) upon mechanical stimuli by von Frey
filaments, was induced by oxaliplatin (OXA). (D) Oxaliplatin-induced cold hyperalgesia (acetone test). The effects of treatments (CBN or OST) on PWT and cold
responses were tested 3 days after oxaliplatin or saline (with 5% glucose) administration. Both CBN (10 mg/kg, i.p.) and OST (10 mg/kg, i.p.) significantly reversed
oxaliplatin-induced mechanical allodynia and cold hyperalgesia. However, neither CBN nor OST significantly changed mechanical or cold responses in saline-treated
animals. Groups of experiments include OXA (oxaliplatin administrated 3 days before the treatment of CBN or OST), saline (saline control for oxaliplatin administrated
3 days before the treatment of CBN or OST), OXA+CBN (CBN administrated 3 days after the treatment of oxaliplatin), OXA+OST (OST administrated 3 days after the
treatment of oxaliplatin), saline+CBN (CBN administrated 3 days after the treatment of saline), and saline+OST (OST administrated 3 days after the treatment of
saline). Values are represented as mean ± SEM. **p < 0.01, OXA vs. saline group; ##p < 0.01, vs. OXA group. Two-way repeated ANOVA followed by post hoc
Bonferroni analysis. N = 6 mice per group.January 2020 | Volume 10 | Article 1522
Su et al. Columbianadin Inhibits Pain and IcaFIGURE 2 | Percentage of the reversing effects of columbianadin (CBN) and osthole (OST) on oxaliplatin-induced mechanical and cold hypersensitivity. The
percentage of the reversing effects was calculated by dividing the CBN or OST-induced difference in PWT or cold score by the oxaliplatin-induced difference in PWT
or cold score. The effects of CBN and OST at 90 min after injection was used for the calculation of the reversing percentage. CBN-3: 3 mg/kg CBN; CBN-10: 10
mg/kg CBN; OST-3: 3 mg/kg OST; OST-10: 10 mg/kg OST. Values are represented as mean ± SEM. *p < 0.1, vs. OST-10, two-tailed independent Student's t-test.
N = 6 mice per group.FIGURE 3 | Dose-dependent effects of columbianadin (CBN) and osthole (OST) on oxaliplatin-induced mechanical allodynia and cold hyperalgesia. Effects of
treatments (CBN or OST) on pain behaviors were tested 3 days after oxaliplatin administration. CBN and OST dose-dependently attenuated oxaliplatin-induced
mechanical and cold pain behaviors. Values are represented as mean± SEM. *p < 0.05, **p < 0.01, vs. vehicle, two-way repeated ANOVA followed by post hoc
Bonferroni analysis. N = 6 mice per group.Frontiers in Pharmacology | www.frontiersin.org January 2020 | Volume 10 | Article 15225
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either pain response. In these behavioral experiments, animals
appeared normal other than the inhibition of the sensory
hypersensitivity following the treatment of CBN or OST.
Effects of Columbianadin on Ica in Small
Dorsal Root Ganglion Cells
The effects of CBN, compared to OST, on the voltage-gated
calcium currents (Ica) of small DRG neurons, most of them are
presumably nociceptive were studied. The series resistance, cell
size, membrane capacitance, cell number, and animal number
for whole-cell recording were included in the Supplemental
Tables 1 and 2. The current-voltage (I–V) relationship of total
Ica (in the absence of any subtype-specific calcium channel
blockers) with or without compounds was firstly compared
(Figure 4). Compared to control, both CBN and OST
significantly suppressed total Ica. Moreover, the suppressing
effect of CBN were significantly larger than that of OST. TheFrontiers in Pharmacology | www.frontiersin.org 6significant voltages of CBN and OST were from −15 to +35 mV,
and from −10 to +35 mV, respectively.
To further study which subtypes of high-threshold calcium
currents are suppressed by CBN and OST, we used subtype-
specific antagonists of calcium channels. For inhibition of L-type
Ica, nimodipine was used. For inhibition of P/Q-type Ica, w-
Agatoxin IVA was used and for inhibition of N-type Ica, w-
Conotoxin MVIIA was used. In the presence of nimodipine, both
CBN and OST did not inhibit Ica significantly (Figure 5).
However, a trend inhibition (P < 0.1) was observed at −25
and −20 mV for CBN, and at +25 mV for OST. In the
presence of either w-Agatoxin IVA or w-Conotoxin MVIIA,
both CBN and OST reduced Ica significantly (Figures 6 and 7).
The significant voltages for CBN and OST in the presence of w-
Agatoxin IVA were from −20 to +35 mV, and from 0 to +35 mV,
respectively (Figure 6). At −20 and −15 mV, CBN and OST
showed a significant difference. The significant voltages of CBN
and OST in the presence of w-Conotoxin MVIIA were from −5FIGURE 4 | Effects of columbianadin (CBN) or osthole (OST) on the I–V currents of total Ica in the absence of any calcium channel blockers in small dorsal root
ganglion (DRG) neurons. (A) Representative whole-cell total Ica recorded from a small DRG neuron (neuron A) in the absence of any compound. Total Ica were
obtained by 200-ms depolarizing pulses from a holding potential of −100 mV to test potentials ranging from −80 to +50 mV in a 5 mV increment. The interpulse time
is 3 s. (B, C) Representative Ica in the presence of 100 mM CBN or 100 mM OST from two different DRG neurons (neuron B and C, respectively). Recordings are all
from independent cells and each cell is only used for a single treatment. CBN or OST were pre-treated for 10–60 min in the recording chamber and maintained
during recordings. The time for pre-treating ranged between 10 and 60 min. (D) Current-voltage relationships of the total Ica in control (black line), OST (blue line),
and CBN (red line) groups. Data points are mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001 vs. control, #p < 0.05, ##p < 0.01, vs. CBN, two-way repeated ANOVA
followed by post hoc Bonferroni analysis.January 2020 | Volume 10 | Article 1522
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Moreover, in the presence of nimodipine, w-Agatoxin IVA and
w-Conotoxin MVIIA together, the transient Ica was evident
(Figure 8A). Both CBN and OST reduced the transient Ica
significantly (Figure 8). The significant voltages for CBN and
OST to inhibit the transient Ica were from −25 to +15 mV, and
from −30 to +25 mV, respectively.
In addition to the IV curves, we further compared the
activation curves of Ica in the absence or presence of calcium
channel antagonists (Figure 9). The half activation voltage (V1/2)
of the total Ica, or the Ica in the presence of either nimodipine or
the cocktail of blockers, was not changed significantly by either
CBN or OST (Figure 9F). Moreover, no significant change in V1/
2 was induced by CBN in the presence of w-Agatoxin IVA or by
OST in the presence of w-Conotoxin MVIIA. However, a
hyperpolarizing shift in V1/2 was observed for CBN in the
presence of w-Conotoxin MVIIA or for OST in the presence of
w-Agatoxin IVA. On the other hand, neither CBN or OST
changed the slope factor (k) in any conditions significantly
(Figure 9G).Frontiers in Pharmacology | www.frontiersin.org 7A shiftment of reversal potential and/or peak voltage of
calcium currents was observed in the presence of CBN or OST
compared to control (Figures 4D, 6D, and 7D). To test if these
changes might be mediated by chloride currents activated at
depolarizing voltages, we used a chloride channel blocker
niflumic acid (Hilaire et al., 2005). We found that in the
presence of 100 µM niflumic acid, CBN-induced changes in
reversal potential and peak voltage of calcium currents were
largely reversed (Supplemental Figure 1).
Effects of Columbianadin on Voltage-
Gated Sodium Current in Small Dorsal
Root Ganglion Cells
To study the effects of CBN and OST on both the tetrodotoxin-
sensitive (TTX-S) and tetrodotoxin-resistant (TTX-R) sodium
currents, a kinetics subtraction protocol was used (Cummins and
Waxman, 1997). As shown in Figure 10, the fast current (the
TTX-S current) was obtained by subtraction of the slow current
(the TTX-R current) from the total current in small DRG
neurons. Compared to control, neither CBN nor OSTFIGURE 5 | Effect of columbianadin (CBN) or osthole (OST) on the I–V current of Ica in the presence of an L-type Ica blocker nimodipine in small dorsal root
ganglion (DRG) neurons. (A) Representative whole-cell Ica in the presence of 2 mM nimodipine (NM) recorded from a small DRG neuron in the absence of any
compound. (B) Representative Ica in the presence of 2 mM nimodipine and 100 mM CBN. (C) Representative Ica in the presence of 2 mM nimodipine and 100 mM
OST. Recordings are all from independent cells and each cell is only used for a single treatment. Nimodipine, CBN, and OST were pre-treated in the same way
described in Figure 4. And the same pretreatment method was used for other calcium channel blockers in the following figures. (D) Current-voltage relationships of
the Ica in nimodipine (black line), during exposure 100 mM OST (blue line) and 100 mM CBN (red line). Data points are mean ± SEM. Data are analyzed by two-way
repeated ANOVA.January 2020 | Volume 10 | Article 1522
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TTX-R current.
Effects of Columbianadin on Oxaliplatin-
Induced Mechanical Allodynia Following
Calcium Channel Inhibition
Our behavior and cellular electrophysiology experiments
suggested that the effects of CBN and OST on neuropathic
pain behaviors might be mediated by inhibiting calcium
channels. To test this suggestion, we further examined the
effects of CBN and OST on the oxaliplatin-induced
mechanical allodynia following the treatment of an Food
and Drug Administration-approved calcium channel blocker
gabapentin. Gabapentin is a first-line treatment for
neuropathic pain associated with peripheral neuropathy in
clinics while patients with this type of pain often do not
respond to nonsteroidal anti-inflammatory drugs or weak
opioids. Gabapentin (30 mg/kg, p.o.) significantly inhibited
oxaliplatin-induced mechanical allodynia (Figure 11).Frontiers in Pharmacology | www.frontiersin.org 8However , nei ther CBN or OST changed the PWT
significantly fol lowing the treatment of gabapentin
compared to the control (Figure 11).DISCUSSION
In the present study, we first studied the effects of CBN and OST
on the nociceptive behaviors in a mouse model of neuropathic
pain induced by oxaliplatin. Oxaliplatin is a platinum-based
chemotherapeutic agent commonly used in the treatment of
colorectal cancer. However, use of oxaliplatin causes a peripheral
neuropathy that is associated with a characteristic sensory
hypersensitivity triggered or exacerbated by cold temperature
(Argyriou et al., 2013; Boyette-Davis et al., 2018). Like other
types of neuropathic pain, current treatments for oxaliplatin-
induced pain are often not effective or with serious side effects. In
the present study, we found that both CBN and OST significantly
inhibited both mechanical and cold hypersensitivity induced byFIGURE 6 | Effect of columbianadin (CBN) or osthole (OST) on the I–V current of Ica in the presence of a P/Q-type Ica blocker w-Agatoxin IVA in small dorsal
root ganglion (DRG) neurons. (A) Representative whole-cell Ica in the presence of 0.2 mM w-Agatoxin IVA (w-AGTX) recorded from a small DRG neuron in the
absence of any compound. (B) Representative Ica in the presence of 0.2 mM w-Agatoxin IVA and 100 mM CBN. (C) Representative Ica in the presence of
0.2 mM w-Agatoxin IVA and 100 mM OST. Recordings are all from independent cells and each cell is only used for a single treatment. (D) Current-voltage
relationships of the Ica in w-Agatoxin IVA (black line), during exposure 100 mM OST (blue line) and 100 mM CBN (red line). Data points are mean ± SEM.
*p < 0.05, **p < 0.01, ***p < 0.001 vs. w-Agatoxin IVA, #p < 0.05, ##p < 0.01, vs. w-Agatoxin IVA +CBN, two-way repeated ANOVA followed by post hoc
Bonferroni analysis.January 2020 | Volume 10 | Article 1522
Su et al. Columbianadin Inhibits Pain and Icaoxaliplatin. Moreover, it appears that the CBN produced a
stronger inhibition on cold hyperalgesia compared to OST.
These results suggest that CBN is effective for both mechanical
and cold sensitivity and OST seems more effective for
mechanical sensitivity.
As peripheral sensitization is a common mechanism for
neuropathic pain, we aimed to test the potential effects of CBN
and OST on ionic currents in DRG neurons. In the previous
studies, OST was found to modulate TRPV channels in DRG
neurons and to modulate calcium channels in other cells (Wu
et al., 2002; Wang et al., 2008; Yang et al., 2016; Sun et al., 2018).
In the present study, we found that both CBN and OST
significantly inhibited total calcium currents in small DRG
neurons. Moreover, the effects of CBN and OST on the
neuropathic pain behaviors were prevented by a calcium
channel blocker gabapentin. These results suggest that
inhibition of voltage-gated calcium currents in nociceptive
DRG neurons might contribute to the inhibitory effects of
CBN and OST on oxaliplatin-induced neuropathic pain
behaviors, as well as on the nociceptive and/or pruriticFrontiers in Pharmacology | www.frontiersin.org 9behaviors observed in other studies (Chen et al., 1995; Yang
et al., 2016; Wu et al., 2017; Singh et al., 2018; Sun et al., 2018;
Yuan et al., 2018). The stronger inhibition of calcium currents
might contribute to the larger effects of CBN on the oxaliplatin-
induced cold hyperalgesia compared to OST.
In the recording of calcium currents particularly when the
amplitude of currents are small following CBN and OST, a
shiftment of reverse potential and/or peak voltage of currents
was observed (Figures 4D, 6D, and 7D). We further found that
the changes in reversal potential and peak voltage of calcium
currents were largely reversed by a chloride channel blocker
niflumic acid (Supplemental Figure 1). These results suggest
that there might be a chloride current activated at depolarizing
voltages that contribute to the changes in the reversal potential
and peak voltage of calcium currents especially when the
amplitude of steady-state calcium currents is small.
We further tested which subtypes of calcium currents might
be involved in the effects of CBN and OST. It has been reported
that OST inhibited L-type calcium current in NG108-15
neuronal cells (Wu et al., 2002) and modulated N-type and P/FIGURE 7 | Effect of columbianadin (CBN) or osthole (OST) on the I–V current of Ica in the presence of N-type Ica blocker w-Conotoxin MVIIA in small dorsal
root ganglion (DRG) neurons. (A) Representative whole-cell Ica in the presence of 1 mM w-Conotoxin MVIIA (w-CNTX) recorded from a small DRG neuron in
the absence of any compound. (B) Representative Ica in the presence of 1 mM w-Conotoxin MVIIA and 100 mM CBN. (C) Representative Ica in the presence
of 1 mM w-Conotoxin MVIIA and 100 mM OST. Recordings are all from independent cells and each cell is only used for a single treatment. (D) Current-voltage
relationships of the Ica in w-Conotoxin MVIIA (black line), during exposure 100 mM OST (blue line) and 100 mM CBN (red line). Data points are mean ± SEM.
*p < 0.05, **p < 0.01, vs. w-Conotoxin MVIIA, two-way repeated ANOVA followed by post hoc Bonferroni analysis.January 2020 | Volume 10 | Article 1522
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hippocampus (Wang et al., 2008). In the present study, we
found that both CBN and OST significantly inhibited the
transient (T-type) calcium currents. For the steady-state
currents, CBN and OST might show some preference to L-
type, compared to N- and P/Q-type currents since significant
inhibition was observed in the presence of either N- or P/Q-, but
not L-type blockers. Overall, these results suggest that CBN and
OST might preferentially inhibited T- and L-type calcium
currents in small DRG neurons.
Calcium channel blockers have been found to inhibit
oxaliplatin-induced pain and/or neuropathy in animal models
and in patients. For instances, both L-type and non-selective
calcium channel blockers reduce sensory neuropathy induced by
oxaliplatin-based chemotherapy in patients (Saif et al., 2010;
Tatsushima et al., 2013). Nevertheless, lack of pain-reducing
effects has also been reported for non-selective blockers
gabapentin and pregabalin (de Andrade et al., 2017; WiffenFrontiers in Pharmacology | www.frontiersin.org 10et al., 2017). In rodent models of oxaliplatin, T-type, L-type,
and non-selective blockers reduce mechanical and/or cold
hyperalgesia (Ling et al., 2008; Gauchan et al., 2009; Kawashiri
et al., 2012; Aoki et al., 2014; Ohsawa et al., 2014; Ruyang et al.,
2015; Di Cesare Mannelli et al., 2017; Sekiguchi et al., 2018).
Moreover, in vitro pre-treatment of oxaliplatin for 24 h
selectively up-regulates T- and L-type calcium channels in
DRG neurons (Schmitt et al., 2018). These results suggest that
T- and L-type calcium channels play critical role in oxaliplatin-
induced neuropathic pain. Therefore, the dual T- and L-type
blockers CBN and OST might be promising candidate for the
development of effective and safe treatment for oxaliplatin-
induced neuropathic pain.
Although the current study suggests that CBN and OST
inhibit calcium currents in DRG neurons, the underlying
mechanisms are not clear. Previous studies have found that
OST can modulate intracellular signal molecules such as cyclic
adenosine monophosphate (cAMP), cyclic guanosineFIGURE 8 | Effects of columbianadin (CBN) or osthole (OST) on the I–V currents of total Ica in the presence of L-, P/Q, and N-type calcium channel blockers in
small dorsal root ganglion (DRG) neurons. (A) Representative whole-cell total Ica recorded from a small DRG neuron in the presence of 2 mM nimodipine, 0.2 mM w-
Agatoxin IVA, and 1 mM w-Conotoxin MVIIA. (B, C) Representative Ica in the presence of calcium channel blockers and 100 mM CBN or 100 mM OST. Recordings
are all from independent cells and each cell is only used for a single treatment. (D) Current-voltage relationships of the Ica in control (black line), OST (blue line), and
CBN (red line) groups. Data points are mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001 vs. control, two-way repeated ANOVA followed by post hoc
Bonferroni analysis.January 2020 | Volume 10 | Article 1522
Su et al. Columbianadin Inhibits Pain and Icamonophosphate (cGMP), and protein kinase C (PKC) (Ko et al.,
1992; Wu et al., 2002; Wang et al., 2008). However, analogues of
cAMP and cGMP do not effectively inhibit calcium currents in
NG108-15 cells (Wu et al., 2002). In addition, a positive
modulation of PKC (Wang et al., 2008) and calcium channels
can not account for the inhibitory effects of CBN and OST in theFrontiers in Pharmacology | www.frontiersin.org 11current study. Overall, it seems that CBN and OSTmight directly
modulate the function of calcium channels by stabilizing the
inactivation state of the channels (Ko et al., 1992; Wang et al.,
2008). On the other hand, it can not be ruled out that the CBN
and OST might inhibit calcium channel through an
indirect mechanism.FIGURE 9 | Effect of columbianadin or osthole on the activation of Ica in small dorsal root ganglion neurons. (A–E) G-V relationships for total Ica, Ica in the presence
of the L-type Ica blocker, Ica in the presence of the P/Q-type Ica blocker, Ica in the presence of the N-type Ica blocker, and Ica in the presence of all types of Ica
blockers, respectively. Curves from individual cells were fit by a single Boltzmann distribution function. (F) Half activation voltages (Vhalf). (G) Slope factors of
activation curves. Data were presented as mean ± SEM. *p < 0.05, vs. control. One-way ANOVA with Tukey's multiple comparisons test.January 2020 | Volume 10 | Article 1522
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Frontiers in Pharmacology | www.frontiersin.org 12In the current study, we used gabapentin to study the
potential cause and effect relationship between the inhibition
of calcium channels and the inhibition of pain behaviors of CBN
and OST. However, because the pain behaviors were already
reduced by gabapentin itself, the effects of CBN and OST on pain
behaviors following gabapentin would be underestimated.
Therefore, the current experiments can not rule out that CBN
and OST might also inhibit pain behaviors through other
mechanisms independent of the inhibition of calcium
channels. Future studies are needed to identify the mechanisms
underlying the effects of CBN and OST on calcium channels in
order to development a strategy to selectively target the effects of
CBN and OST on calcium channels.
The current study suggests that CBN and OST might display
different efficacy inhibiting calcium channels. Although the
parent nucleus of CBN and OST is same (as 1,2-benzopyrone),
the side chains are different. There are two side chains in OST
including a 7-methoxy and 8-isopentenyl. For CBN, there is a
furan in the side chain. Moreover, the CBN can be derived from
OST through a synthesis of the furan by the 7-methoxy and 8-
isopentenyl after a breakdown of the double bonds in the 8-
isopentenyl, combined with a substitution of isopentenic acid at
the same time. Therefore, the different but derivable side chainsFIGURE 10 | Effects of columbianadin on the fast current (the TTX-S current) and the slow current (the TTX-R current) in small dorsal root ganglion (DRG) neurons.
(A) Representative total, TTX-S and TTX-R current recorded from a small DRG neuron in the absence of any compound. (B–C) Representative total, TTX-S and TTX-
R current in the presence of 100 mM columbianadin (CBN) or 100 mM osthole (OST), respectively. Recordings are all from independent cells and each cell is only
used for a single treatment. (D–E) Current density of TTX-S and TTX-R current in control, CBN and OST groups. Data were presented as mean ± SEM. One-way
ANOVA with Tukey's multiple comparisons test.FIGURE 11 | Effects of columbianadin (CBN) and osthole (OST) on oxaliplatin-
induced mechanical allodynia in the presence of gabapentin. Mechanical allodynia
was induced by oxaliplatin (OXA). Gabapentin was administrated (30 mg/kg, p.o.,
single administration) 3 days after oxaliplatin treatment. CBN (10 mg/kg), OST (10
mg/kg), or saline (with 2% DMSO) was administrated (i.p.) 90 min after the
treatment of gabapentin. Both CBN and OST (10 mg/kg, i.p.) did not change
PWT compared to saline group (two-way repeated ANOVA). Values are
represented as mean± SEM. *p < 0.05, **p < 0.01, 90 min post-gabapentin vs.
pre-gabapentin; paired student t test. N = 6 mice per group.January 2020 | Volume 10 | Article 1522
Su et al. Columbianadin Inhibits Pain and Icamight contribute to the different efficacy of CBN and OST
inhibiting calcium channels.
In summary, we found that a major coumarin of RAP, CBN
displayed strong anti-nociceptive effects in a neuropathic pain
model likely through a preferential inhibition of T- and L-type
calcium currents in small DRG neurons.DATA AVAILABILITY STATEMENT
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